Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysis
Authors
Keywords
-
Journal
HIV CLINICAL TRIALS
Volume 16, Issue 5, Pages 178-189
Publisher
Informa UK Limited
Online
2015-09-23
DOI
10.1179/1945577115y.0000000004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Cardiovascular Events Associated With Current Exposure to HIV Antiretroviral Therapies in a US Veteran Population
- (2015) Manisha Desai et al. CLINICAL INFECTIOUS DISEASES
- HIV infection and cardiovascular disease
- (2014) L. G. Hemkens et al. EUROPEAN HEART JOURNAL
- Virological efficacy of abacavir: systematic review and meta-analysis
- (2014) M. Cruciani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reducing waste from incomplete or unusable reports of biomedical research
- (2014) Paul Glasziou et al. LANCET
- Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
- (2014) François Raffi et al. LANCET
- The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health
- (2014) Roger J. Bedimo et al. PLoS One
- Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1
- (2013) Eric S. Daar ANNALS OF INTERNAL MEDICINE
- A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients
- (2013) CN Menezes et al. HIV MEDICINE
- Abacavir/Lamivudine versus Tenofovir/Emtricitabine with Atazanavir/Ritonavir for Treatment-naive Japanese Patients with HIV-1 Infection: A Randomized Multicenter Trial
- (2013) Takeshi Nishijima et al. INTERNAL MEDICINE
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
- (2012) Roger Bedimo et al. AIDS
- A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine
- (2012) Nittaya Phanuphak et al. ANTIVIRAL THERAPY
- Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis
- (2012) Fakhrul M Islam et al. BMC PUBLIC HEALTH
- The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV-infected patients: a randomized trial
- (2012) CN Menezes et al. HIV MEDICINE
- Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients
- (2012) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
- (2012) Thomas B. Campbell et al. PLOS MEDICINE
- Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
- (2011) Andy I Choi et al. AIDS
- Incidence of low and high-energy fractures in persons with and without HIV infection
- (2011) Ann-Brit E. Hansen et al. AIDS
- Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s
- (2011) G. A. McComsey et al. CLINICAL INFECTIOUS DISEASES
- Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results
- (2011) Jacques Reynes et al. HIV CLINICAL TRIALS
- Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results
- (2011) Paul E. Sax et al. JOURNAL OF INFECTIOUS DISEASES
- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study
- (2010) Hans‐Jürgen Stellbrink et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites
- (2010) WH Belloso et al. HIV MEDICINE
- Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study
- (2010) Frank A Post et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
- (2009) Kimberly Y Smith et al. AIDS
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy
- (2009) Paul E. Sax et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand
- (2008) Gail V. Matthews et al. HEPATOLOGY
- Reasons or excuses for avoiding meta-analysis in forest plots
- (2008) John P A Ioannidis et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation